# Charles River Laboratories International (CRL) — News CRL · NYSE · Stock Canonical page: https://www.lighthorse.io/tickers/crl/news ## Recent headlines - [Exail Technologies SA: Berenberg cuts target price to EUR 134 from EUR 145](https://www.ainvest.com/news/exail-technologies-sa-berenberg-cuts-target-price-eur-134-eur-145-2610) — AInvest Wire, Oct 12, 2026 Berenberg Bank has revised its price target for Exail Technologies SA (Euronext Paris: EXA), lowering it to EUR 134 from EUR 145, while maintaining a "Buy" rating on the stock. The adjustment reflects ongoing developments in the company’s strategic and financial landscape, including recent analyst… - [Charles River, Autolomous launch Apollo orchestrate platform](https://www.ainvest.com/news/charles-river-autolomous-launch-apollo-orchestrate-platform-2610) — AInvest Wire, Oct 6, 2026 On October 6, 2026, Charles River Laboratories and Autolomous announced the launch of an Apollo orchestrate platform, a collaborative initiative aimed at advancing autonomous vehicle technology through integrated software and hardware solutions. The platform builds on the foundational work of… - [Charles River Laboratories International - Co and Autolomous launch Apollo orchestrate within Apollo platform](https://www.ainvest.com/news/charles-river-laboratories-international-autolomous-launch-apollo-orchestrate-apollo-platform-2610) — AInvest Wire, Oct 6, 2026 - [Charles River Laboratories International, Inc.: UBS raises to buy from neutral](https://www.ainvest.com/news/charles-river-laboratories-international-ubs-raises-buy-neutral-2609) — AInvest Wire, Sep 30, 2026 On September 30, 2026, UBS analyst Dan Leonard upgraded Charles River Laboratories International, Inc. (NYSE: CRL) to a "Buy" rating from "Neutral," according to recent analyst updates . This move reflects a more positive outlook on the company’s prospects, potentially influenced by its role in the… - [Charles River Laboratories International, Inc.: Jefferies raises target price to $340 from $305](https://www.ainvest.com/news/charles-river-laboratories-international-jefferies-raises-target-price-340-305-2609) — AInvest Wire, Sep 28, 2026 Jefferies has revised its price target for Charles River Laboratories International, Inc. (CRL) to $340 from $305, reflecting an increased outlook for the company’s stock performance[1]. The adjustment follows an analysis of the firm’s recent financial results and market positioning. Charles River… ## Similar Stocks - [IQV](https://www.lighthorse.io/tickers/iqv) — IQVIA Holdings, Inc. Common Stock - [RVTY](https://www.lighthorse.io/tickers/rvty) — Revvity, Inc. Common Stock - [TECH](https://www.lighthorse.io/tickers/tech) — Bio-Techne Corp - Common Stock - [TMO](https://www.lighthorse.io/tickers/tmo) — Thermo Fisher Scientific Inc Common Stock - [A](https://www.lighthorse.io/tickers/a) — Agilent Technologies, Inc. Common Stock - [ICLR](https://www.lighthorse.io/tickers/iclr) — ICON plc - Ordinary Shares --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).